Guanfacine

Drug Usage Statistics, United States, 2005 - 2015

Number of Prescriptions Over Time (2005 - 2015)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2004 357 -
2005 490  133
2006 358  132
2007 372  14
2008 423  51
2009 356  67
Year Rank Change
2010 269  87
2011 241  28
2012 203  38
2013 225  22
2014 228  3
2015 183  45

Patient Out-Of-Pocket Cost Over Time (2005 - 2015)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2015)
Clonidine 10,896,073
Guanfacine (this drug) 3,389,253

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Intuniv
  • Tenex
Generic Drug Synonyms and Salts
  • Guanfacine Hydrochloride
  • Guanfacine

FDA Approval Information

Established Pharmacologic Class (EPC): Central alpha-2 Adrenergic Agonist
Initial FDA approval date: 10/27/1986
First FDA applicant: Rx
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2005-2015. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 18.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Learning from notecards is so 1900s... Quickly learn drug therapy with our HD videos. The Top 250 Drugs by ClinCalc Academy
©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top
Top